Clinical Trial Update: Preventive Effect of Acetyl-L-carnitine on Oxaliplatin-induced Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial assessing whether Acetyl-L-carnitine can prevent Oxaliplatin-induced peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Acetylcarnitine, Chemotherapy-induced Peripheral Neuropathy | Phase 2 | Status: UNKNOWN